{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:44:20Z","timestamp":1791319460191,"version":"4.3.1"},"reference-count":121,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T00:00:00Z","timestamp":1491955200000},"content-version":"am","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Research Council UK"},{"name":"EASL"},{"name":"Saint Louis University"},{"DOI":"10.13039\/100006370","name":"SBIR","doi-asserted-by":"publisher","award":["1R43DK108606"],"award-info":[{"award-number":["1R43DK108606"]}],"id":[{"id":"10.13039\/100006370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jhep.2016.01.028","type":"journal-article","created":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T19:30:43Z","timestamp":1460489443000},"page":"S60-S70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":145,"special_numbering":"S","title":["The role of innate immunity in the immunopathology and treatment of HBV infection"],"prefix":"10.1016","volume":"64","author":[{"given":"Mala K.","family":"Maini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Gehring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2016.01.028_b0005","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1084\/jem.20140507","article-title":"MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usage","volume":"211","author":"Gold","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2016.01.028_b0010","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature07665","article-title":"Adaptive immune features of natural killer cells","volume":"457","author":"Sun","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.01.028_b0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jhep.2016.01.028_b0020","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.4049\/jimmunol.163.4.2314","article-title":"The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns","volume":"163","author":"Doherty","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2016.01.028_b0025","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20061287","article-title":"Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage","volume":"204","author":"Dunn","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2016.01.028_b0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4291\/wjgp.v6.i3.43","article-title":"Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis","volume":"6","author":"Hammerich","year":"2015","journal-title":"World J Gastrointest Pathophysiol"},{"key":"10.1016\/j.jhep.2016.01.028_b0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004210","article-title":"Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver","volume":"10","author":"Jo","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2016.01.028_b0040","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1038\/ncomms4866","article-title":"Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRbeta repertoire","volume":"5","author":"Lepore","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2016.01.028_b0045","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","article-title":"Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis","volume":"39","author":"McHedlidze","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2016.01.028_b0050","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/hep.27254","article-title":"Immune tolerance in liver disease","volume":"60","author":"Crispe","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.01.028_b0055","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.25497","article-title":"Hypoxia and hypoxia inducible factors: diverse roles in liver diseases","volume":"55","author":"Nath","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.01.028_b0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri3169","article-title":"Living in the liver: hepatic infections","volume":"12","author":"Protzer","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2016.01.028_b0065","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.4049\/jimmunol.175.5.3165","article-title":"Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2","volume":"175","author":"Cooper","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2016.01.028_b0070","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.4049\/jimmunol.1500839","article-title":"Kupffer cells support hepatitis B virus-mediated CD8+ T cell exhaustion via hepatitis B core antigen-TLR2 interactions in mice","volume":"195","author":"Li","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2016.01.028_b0075","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/jmv.10425","article-title":"Saccharomyces cerevisiae-derived HBsAg preparations differ in their attachment to monocytes, immune-suppressive potential, and T-cell immunogenicity","volume":"70","author":"Vanlandschoot","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2016.01.028_b0080","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1099\/0022-1317-83-9-2279","article-title":"LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles","volume":"83","author":"Vanlandschoot","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2016.01.028_b0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.immuni.2014.12.016","article-title":"The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus","volume":"42","author":"Sato","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2016.01.028_b0090","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1128\/JVI.01263-15","article-title":"Viral DNA-dependent induction of innate immune response to hepatitis B virus in immortalized mouse hepatocytes","volume":"90","author":"Cui","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.01.028_b0095","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1128\/JVI.76.10.4848-4854.2002","article-title":"A small molecule inhibits and misdirects assembly of hepatitis B virus capsids","volume":"76","author":"Zlotnick","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.01.028_b0100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.antiviral.2014.05.007","article-title":"Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity","volume":"108","author":"Cai","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jhep.2016.01.028_b0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.antiviral.2013.06.007","article-title":"Beta-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity","volume":"99","author":"Hu","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jhep.2016.01.028_b0110","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1128\/AAC.04617-14","article-title":"Hydroxylated tropolones inhibit hepatitis B virus replication by blocking viral ribonuclease H activity","volume":"59","author":"Lu","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2016.01.028_b0115","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1136\/gutjnl-2011-301073","article-title":"Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection","volume":"61","author":"Bertoletti","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.01.028_b0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.23230","article-title":"Control of hepatitis B virus replication by innate response of HepaRG cells","volume":"51","author":"Lucifora","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.01.028_b0125","doi-asserted-by":"crossref","first-page":"12193","DOI":"10.1073\/pnas.1412631111","article-title":"Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems","volume":"111","author":"Shlomai","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2016.01.028_b0130","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jhep.2015.07.014","article-title":"Early inhibition of hepatocyte innate responses by hepatitis B virus","volume":"63","author":"Luangsay","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.01.028_b0135","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/hep.22751","article-title":"Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells","volume":"49","author":"Wu","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.01.028_b0140","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1053\/j.gastro.2011.02.057","article-title":"Hepatitis B virus limits response of human hepatocytes to interferon-alpha in chimeric mice","volume":"140","author":"Lutgehetmann","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.01.028_b0145","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/j.gastro.2009.06.054","article-title":"Temporal analysis of early immune responses in patients with acute hepatitis B virus infection","volume":"137","author":"Dunn","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.01.028_b0150","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/JVI.01844-08","article-title":"Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections","volume":"83","author":"Stacey","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.01.028_b0155","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2016.01.028_b0160","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.4049\/jimmunol.1103139","article-title":"IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection","volume":"189","author":"Das","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2016.01.028_b0165","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/hep.27793","article-title":"Liver inflammation abrogates immunological tolerance induced by Kupffer cells","volume":"62","author":"Heymann","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.01.028_b0170","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.21844","article-title":"The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection","volume":"46","author":"Chang","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.01.028_b0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hep.27805","article-title":"Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells","volume":"62","author":"Vanwolleghem","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.01.028_b0180","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1038\/ncomms7588","article-title":"Trained immunity in newborn infants of HBV-infected mothers","volume":"6","author":"Hong","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2016.01.028_b0185","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.192.7.921","article-title":"Natural killer T cell activation inhibits hepatitis B virus replication in vivo","volume":"192","author":"Kakimi","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2016.01.028_b0190","doi-asserted-by":"crossref","first-page":"13825","DOI":"10.1073\/pnas.202398599","article-title":"Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection","volume":"99","author":"Yang","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2016.01.028_b0195","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/gut.2008.163600","article-title":"Early kinetics of innate and adaptive immune responses during Hepatitis B Virus infection","volume":"58","author":"Fisicaro","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.01.028_b0200","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1128\/JVI.01022-08","article-title":"Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus","volume":"82","author":"Guy","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.01.028_b0205","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1053\/jhep.2000.19324","article-title":"Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms","volume":"32","author":"Webster","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.01.028_b0210","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1053\/j.gastro.2009.05.047","article-title":"Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections","volume":"137","author":"Oliviero","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.01.028_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001227","article-title":"Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection","volume":"6","author":"Peppa","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2016.01.028_b0220","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jhep.2010.07.009","article-title":"Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B","volume":"54","author":"Tjwa","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.01.028_b0225","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.25651","article-title":"Severe necroinflammatory reaction caused by natural killer cell-mediated Fas\/Fas ligand interaction and dendritic cells in human hepatocyte chimeric mouse","volume":"56","author":"Okazaki","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.01.028_b0230","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.23977","article-title":"Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients","volume":"53","author":"Zhang","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.01.028_b0235","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/imr.12315","article-title":"NK cells: tuned by peptide?","volume":"267","author":"Das","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jhep.2016.01.028_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001900","article-title":"Selection of an HLA-C\u221703:04-restricted HIV-1 p24 Gag sequence variant is associated with viral escape from KIR2DL3+ natural killer cells: data from an observational cohort in South Africa","volume":"12","author":"Holzemer","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.jhep.2016.01.028_b0245","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ni.3227","article-title":"Antigen-specific NK cell memory in rhesus macaques","volume":"16","author":"Reeves","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2016.01.028_b0250","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fimmu.2013.00057","article-title":"NK cells: a double-edged sword in chronic hepatitis B virus infection","volume":"4","author":"Maini","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2016.01.028_b0255","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20121172","article-title":"Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion","volume":"210","author":"Peppa","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2016.01.028_b0260","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.it.2013.03.002","article-title":"Natural killer cells regulate diverse T cell responses","volume":"34","author":"Crome","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jhep.2016.01.028_b0265","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature10624","article-title":"Natural killer cells act as rheostats modulating antiviral T cells","volume":"481","author":"Waggoner","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.01.028_b0270","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.coviro.2015.10.008","article-title":"Roles of natural killer cells in antiviral immunity","volume":"16","author":"Waggoner","year":"2015","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.jhep.2016.01.028_b0275","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1038\/ncomms7375","article-title":"Generation of cellular immune memory and B-cell immunity is impaired by natural killer cells","volume":"6","author":"Rydyznski","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2016.01.028_b0280","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.immuni.2015.05.011","article-title":"Bone-marrow-resident NK cells prime monocytes for regulatory function during infection","volume":"42","author":"Askenase","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2016.01.028_b0285","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/gutjnl-2011-301400","article-title":"NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis","volume":"61","author":"Gur","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.01.028_b0290","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/hep.25804","article-title":"Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis","volume":"56","author":"Kramer","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.01.028_b0295","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1084\/jem.20131560","article-title":"T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow","volume":"211","author":"Daussy","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2016.01.028_b0300","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/ni.1953","article-title":"Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses","volume":"11","author":"Paust","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2016.01.028_b0305","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1172\/JCI66381","article-title":"Liver-resident NK cells confer adaptive immunity in skin-contact inflammation","volume":"123","author":"Peng","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2016.01.028_b0310","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01659","article-title":"Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells","volume":"3","author":"Sojka","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.jhep.2016.01.028_b0315","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1074-7613(02)00305-9","article-title":"Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection","volume":"16","author":"Baron","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2016.01.028_b0320","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nm.2811","article-title":"Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity","volume":"18","author":"Zeissig","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2016.01.028_b0325","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.4049\/jimmunol.1203218","article-title":"IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells","volume":"190","author":"Tang","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2016.01.028_b0330","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.immuni.2013.08.007","article-title":"Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes","volume":"39","author":"Jakubzick","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2016.01.028_b0335","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1182\/blood-2008-02-139634","article-title":"Neutrophil secretion products pave the way for inflammatory monocytes","volume":"112","author":"Soehnlein","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2016.01.028_b0340","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri3671","article-title":"Monocytes and macrophages: developmental pathways and tissue homeostasis","volume":"14","author":"Ginhoux","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2016.01.028_b0345","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","article-title":"Macrophage heterogeneity in liver injury and fibrosis","volume":"60","author":"Tacke","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.01.028_b0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011049","article-title":"Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis","volume":"5","author":"Zimmermann","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2016.01.028_b0355","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1172\/JCI66043","article-title":"Mobilizing monocytes to cross-present circulating viral antigen in chronic infection","volume":"123","author":"Gehring","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2016.01.028_b0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097006","article-title":"Monocytes from chronic HBV patients react in vitro to HBsAg and TLR by producing cytokines irrespective of stage of disease","volume":"9","author":"Boltjes","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2016.01.028_b0365","article-title":"Hyper-activated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2016.01.028_b0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004032","article-title":"Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages","volume":"10","author":"Bility","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2016.01.028_b0375","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hep.26016","article-title":"Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics","volume":"57","author":"Liaskou","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.01.028_b0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002061","article-title":"Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis","volume":"7","author":"Sitia","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2016.01.028_b0385","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/hep.21897","article-title":"Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice","volume":"46","author":"Wu","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.01.028_b0390","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.23226","article-title":"Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection","volume":"50","author":"Hosel","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.01.028_b0395","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/infdis\/jiu599","article-title":"Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function","volume":"211","author":"Boltjes","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2016.01.028_b0400","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.immuni.2014.12.020","article-title":"Liver-resident macrophage necroptosis orchestrates type 1 microbicidal inflammation and type-2-mediated tissue repair during bacterial infection","volume":"42","author":"Bleriot","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2016.01.028_b0405","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jhep.2010.04.037","article-title":"Characterization of two F4\/80-positive Kupffer cell subsets by their function and phenotype in mice","volume":"53","author":"Kinoshita","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.01.028_b0410","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1182\/blood-2007-02-073841","article-title":"Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages","volume":"110","author":"Klein","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2016.01.028_b0415","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1128\/JVI.03733-14","article-title":"Inflammatory monocytes recruited to the liver within 24 hours after virus-induced inflammation resemble Kupffer cells but are functionally distinct","volume":"89","author":"Movita","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.01.028_b0420","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jhep.2014.10.006","article-title":"The immunophenotype of antigen presenting cells of the mononuclear phagocyte system in normal human liver \u2013 a systematic review","volume":"62","author":"Strauss","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.01.028_b0425","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.04.005","article-title":"Metabolic pathways in immune cell activation and quiescence","volume":"38","author":"Pearce","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2016.01.028_b0430","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2016.01.028_b0435","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nm.3856","article-title":"Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells","volume":"21","author":"Pallett","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2016.01.028_b0440","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.4049\/jimmunol.1400849","article-title":"Myeloid-derived suppressor cells regulate immune response in patients with chronic hepatitis B virus infection through PD-1-induced IL-10","volume":"193","author":"Huang","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2016.01.028_b0445","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.20091474","article-title":"Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function","volume":"207","author":"Sander","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2016.01.028_b0450","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2013.04.033","article-title":"Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion","volume":"59","author":"Hochst","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.01.028_b0455","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.24162","article-title":"Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice","volume":"53","author":"Chou","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.01.028_b0460","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.4049\/jimmunol.1303432","article-title":"GammadeltaT cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance","volume":"193","author":"Kong","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2016.01.028_b0465","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.4049\/jimmunol.1501362","article-title":"Polarization of monocytic myeloid-derived suppressor cells by hepatitis B surface antigen is mediated via ERK\/IL-6\/STAT3 signaling feedback and restrains the activation of T cells in chronic hepatitis B virus infection","volume":"195","author":"Fang","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2016.01.028_b0470","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1128\/JVI.79.11.7269-7272.2005","article-title":"Toll-like receptor signaling inhibits hepatitis B virus replication in vivo","volume":"79","author":"Isogawa","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.01.028_b0475","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1128\/JVI.02008-08","article-title":"Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells","volume":"83","author":"Guo","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.01.028_b0480","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jhep.2014.12.026","article-title":"Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B","volume":"62","author":"Menne","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.01.028_b0485","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1053\/j.gastro.2013.02.003","article-title":"GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees","volume":"144","author":"Lanford","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.01.028_b0490","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jhep.2015.02.037","article-title":"The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection","volume":"63","author":"Gane","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.01.028_b0495","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/8fa70b21-32e7-4ed3-b397-ab776b5bbf30","article-title":"Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity","volume":"9","author":"Goulet","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2016.01.028_b0500","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ni.2573","article-title":"Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection","volume":"14","author":"Huang","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2016.01.028_b0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003208","article-title":"The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells","volume":"9","author":"Schurich","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2016.01.028_b0510","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/hep.25875","article-title":"Targeted delivery of interferon-alpha to hepatitis B virus-infected cells using T-cell receptor-like antibodies","volume":"56","author":"Ji","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.01.028_b0515","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhep.2015.02.048","article-title":"Liver-directed gene therapy of chronic hepadnavirus infection using interferon alpha tethered to apolipoprotein A-I","volume":"63","author":"Berraondo","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.01.028_b0520","doi-asserted-by":"crossref","first-page":"9200","DOI":"10.1128\/JVI.00933-15","article-title":"The interferon-inducible protein tetherin inhibits hepatitis B virus virion secretion","volume":"89","author":"Yan","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.01.028_b0525","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jhep.2016.01.028_b0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005103","article-title":"Intrahepatic transcriptional signature associated with response to interferon-alpha treatment in the woodchuck model of chronic hepatitis B","volume":"11","author":"Fletcher","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2016.01.028_b0535","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jhep.2012.09.029","article-title":"Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B","volume":"58","author":"Micco","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.01.028_b0540","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jhep.2011.12.032","article-title":"Peginterferon-alpha does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis","volume":"56","author":"Penna","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.01.028_b0545","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/jir.2014.0227","article-title":"Disease-promoting effects of type I interferons in viral, bacterial, and coinfections","volume":"35","author":"Davidson","year":"2015","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jhep.2016.01.028_b0550","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.07.014","article-title":"Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues","volume":"143","author":"Boni","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.01.028_b0555","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jhep.2014.06.017","article-title":"Direct-acting antivirals trump interferon-alpha in their capacity to rescue exhausted T cells upon HCV clearance","volume":"61","author":"Maini","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.01.028_b0560","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2014.05.043","article-title":"Restoration of HCV-specific CD8+ T cell function by interferon-free therapy","volume":"61","author":"Martin","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.01.028_b0565","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/infdis\/jiv180","article-title":"Natural killer cell characteristics in patients with chronic hepatitis B virus (HBV) infection are associated with HBV surface antigen clearance after combination treatment with pegylated interferon Alfa-2a and adefovir","volume":"212","author":"Stelma","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2016.01.028_b0570","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jhep.2013.08.020","article-title":"Reduction of HBV replication prolongs the early immunological response to IFNalpha therapy","volume":"60","author":"Tan","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.01.028_b0575","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jhep.2012.11.007","article-title":"Dissecting the divergent effects of interferon-alpha on immune cells: time to rethink combination therapy in chronic hepatitis B?","volume":"58","author":"Thimme","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.01.028_b0580","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/hep.28155","article-title":"Natural killer cell phenotype modulation and natural killer\/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B","volume":"62","author":"Boni","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.01.028_b0585","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.it.2015.07.004","article-title":"Boosting vaccine efficacy the natural (killer) way","volume":"36","author":"Rydyznski","year":"2015","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jhep.2016.01.028_b0590","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1084\/jem.20052119","article-title":"Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery","volume":"203","author":"Tacke","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2016.01.028_b0595","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cellimm.2010.10.003","article-title":"Preserved MHC-II antigen processing and presentation function in chronic HCV infection","volume":"266","author":"Canaday","year":"2011","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jhep.2016.01.028_b0600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009491","article-title":"Preserved MHC class II antigen processing in monocytes from HIV-infected individuals","volume":"5","author":"Woc-Colburn","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2016.01.028_b0605","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3389\/fonc.2014.00349","article-title":"Myeloid-derived suppressor cells as therapeutic target in hematological malignancies","volume":"4","author":"De Veirman","year":"2014","journal-title":"Front Oncol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816000647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816000647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T22:27:51Z","timestamp":1712356071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827816000647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":121,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0168827816000647"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2016.01.028","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of innate immunity in the immunopathology and treatment of HBV infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2016.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}